# Autologous ex Vivo Conjunctival Epithelial Cell Expansion for Ocular Surface Transplantation

> **NCT00346450** · PHASE3 · COMPLETED · sponsor: **Singapore National Eye Centre** · enrollment: 80 (estimated)

## Conditions studied

- Pterygium
- Ocular Surface Disease
- Stevens Johnson Syndrome
- Chemical Injury

## Interventions

- **PROCEDURE:** Cultivated conjunctival transplantation

## Key facts

- **NCT ID:** NCT00346450
- **Lead sponsor:** Singapore National Eye Centre
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-10
- **Primary completion:** —
- **Final completion:** 2003-12
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2010-01-13

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00346450

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00346450, "Autologous ex Vivo Conjunctival Epithelial Cell Expansion for Ocular Surface Transplantation". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00346450. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*